Search

everythinglearnresearchcommunity

for

Search:↓

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Obese women with PCOS are more likely to have fatty liver disease.

Blood pressure that doesn't drop at night is linked to worse blood vessel function in people with high blood pressure.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

PAD is common but often missed, needing lifestyle changes and medication for better outcomes.

Early recognition and treatment of Peripheral Arterial Disease is crucial to improve survival and health outcomes.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

High testosterone increases heart disease risk in women with PCOS.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Anorexia and bulimia lead to serious health problems and increased risk of death, requiring aggressive treatment.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Minoxidil improves blood flow in heart failure patients.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Minoxidil, propranolol, and furosemide effectively control severe hypertension, but may cause sodium retention.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Subcutaneous contraceptives can cause side effects like menstrual changes, headaches, weight gain, and pain at the implant site.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Minoxidil helps control blood pressure but has side-effects, so it's not for everyone.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.